Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer’s Disease by Removal of Blood Amyloid
The DOI matches its Crossref record; 14 of the 15 references it cites were found in a registry or an index.
Abstract
As a proof of concept that removal of blood amyloid-β (Aβ) can reduce Aβ deposition in the brains of patients with Alzheimer’s disease, cortices of patients who had undergone hemodialysis (HD), which removes Aβ from the blood, were histochemically analyzed; postmortem brain sections were stained with anti-Aβ antibodies. Brains from patients who had undergone HD had significantly fewer senile plaques than those of patient who had not undergone HD. This significant difference was also confirmed by silver staining. Our findings suggest that removal of blood Aβ by hemodialysis results in lower accumulation of Aβ in the brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients with CKD and animals undergoing unilateral nephrectomy exhibit elevated levels of circulating and cerebral Aβ, along with impaired cognition.254–256”
From Antiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances (2025) · cites this paper as [256]
Citations
Cites
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Decreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078
Intraneuronal Aβ42 Accumulation in Human Brain
Gouras, G. K., Tsai, J., Naslund, J., Vincent, B., Edgar, M., Checler, F., Greenfield, J. P., Haroutunian, V., Buxbaum, J. D., Xu, H., et al. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64700-1 · Cited by 991
Bouras, C., Hof, P. R., Giannakopoulos, P., Michel, J.-P., & Morrison, J. H. (1994) · Cerebral Cortex · doi:10.1093/cercor/4.2.138 · Cited by 280
Intraneuronal Aβ-Amyloid Precedes Development of Amyloid Plaques in Down Syndrome
Gyure, K. A., Durham, R., Stewart, W. F., Smialek, J. E., & Troncoso, J. C. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-0489-iaapdo · Cited by 248
Diffuse type of senile plaques in the brains of Alzheimer-type dementia
Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., & Harigaya, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00687420 · Cited by 235
Braak, H., Braak, E., Ohm, T., & Bohl, J. (1988) · Stain Technology · doi:10.3109/10520298809107184 · Cited by 171
Wiesehan, K., Buder, K., Linke, R. P., Patt, S., Stoldt, M., Unger, E., Schmitt, B., Bucci, E., & Willbold, D. (2003) · ChemBioChem · doi:10.1002/cbic.200300631 · Cited by 171
Plasma amyloid levels and the risk of AD in normal subjects in the Cardiovascular Health Study
Lopez, O. L., Kuller, L. H., Mehta, P. D., Becker, J. T., Gach, H. M., Sweet, R. A., Chang, Y. F., Tracy, R., & DeKosky, S. T. (2008) · Neurology · doi:10.1212/01.wnl.0000306696.82017.66 · Cited by 161
Amyloid β 38, 40, and 42 species in cerebrospinal fluid: More of the same?
Schoonenboom, N. S., Mulder, C., Van Kamp, G. J., Mehta, S. P., Scheltens, P., Blankenstein, M. A., & Mehta, P. D. (2005) · Annals of Neurology · doi:10.1002/ana.20508 · Cited by 120
Kitaguchi, N., Hasegawa, M., Ito, S., Kawaguchi, K., Hiki, Y., Nakai, S., Suzuki, N., Shimano, Y., Ishida, O., Kushimoto, H., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1431-3 · Cited by 42
Self-citationKatô, M., Kawaguchi, K., Nakai, S., Murakami, K., Hori, H., Ohashi, A., Hiki, Y., Ito, S., Shimano, Y., Suzuki, N., et al. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0844-5 · Cited by 34
Self-citationKitaguchi, N., Kawaguchi, K., Nakai, S., Murakami, K., Ito, S., Hoshino, H., Hori, H., Ohashi, A., Shimano, Y., Suzuki, N., et al. (2011) · Blood Purification · doi:10.1159/000322624 · Cited by 28
Self-citationKawaguchi, K., Kitaguchi, N., Nakai, S., Murakami, K., Asakura, K., Mutoh, T., Fujita, Y., & Sugiyama, S. (2010) · Journal of Artificial Organs · doi:10.1007/s10047-010-0482-3 · Cited by 25
Self-citation
Research works printed but not linked: 1
- KimKS, MillerDL, SapienzaVJ, ChenCMJ, BaiC, Grundke-IqbalI, CurrieJR, WisniewskiHM (1988) Production and characterization of monoclonal antibodies reactive to synthetic cerebrovascular amyloid peptide. Neurosci Res Commun 2, 121–130.
Cited by
A systemic view of Alzheimer disease — insights from amyloid-β metabolism beyond the brain
Wang, J., Gu, B. J., Masters, C. L., & Wang, Y.-J. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.111 · Cited by 808
Cheng, Y., Tian, D.-Y., & Wang, Y.-J. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00195-1 · Cited by 190
“Aβ deposition is observed in the brains of CKD patients [94].”
InfluentialAntiageing strategy for neurodegenerative diseases: from mechanisms to clinical advances
Jiang, Q., Liu, J., Huang, S., Wang, X.-Y., Chen, X., Liu, G.-H., Ye, K., Song, W., Masters, C. L., Wang, J., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02145-7 · Cited by 165
“256 In addition, renal insuf fi ciency also leads to increased levels of circulating uraemic neurotoxins such as parathyroid hormone and neuropeptide Y, which adversely affect hippocampal neuronal apoptosis and the permeability of the BBB, respectively.”
Jin, W., Shen, L., Bu, X., Zhang, W., Chen, S., Huang, Z., Xiong, J., Gao, C., Dong, Z., He, Y., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1721-y · Cited by 129
“Previous clinical studies have suggested that dialysis reduces blood Aβ levels [22, 25, 34, 39].”
An Integrated View on Vascular Dysfunction in Alzheimer’s Disease
Klohs, J. (2019) · Neurodegenerative Diseases · doi:10.1159/000505625 · Cited by 111
Metadata
- Authors
- Sakai, K., Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., & Kitaguchi, N.
- Affiliations
- Fujita Health University (JP)
- Department of Nephrology, School of Medicine, Fujita Health University, Toyoake, Japan
- Corresponding author
- Kitaguchi, Nobuya
- ORCID
- Venue
- Journal of Alzheimer’s Disease
- Publisher
- SAGE Publications
- Published
- 2016-02-20
- Volume
- 51
- Issue
- 4
- Pages
- 997-1002
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2275719381
- Cited by
- 43
- References
- 15
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 6 · 2021: 5 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 4
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (25462645, 26282126, 26462772)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Clinical Neurology › Cerebrospinal fluid and hydrocephalus
- Keywords
- hemodialysis, amyloid-beta
- MeSH terms
- Aged, Aged, 80 and over, Autopsy, Brain, Renal Dialysis, Humans, Kidney Diseases, Case-Control Studies, Amyloid beta-Peptides, Silver Staining, Statistics, Nonparametric, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.